Medtronic (MDT) Q2 2025 Annual Earnings
Medtronic reported Q2 2025 revenue of $8.9B (+3.9% YoY), beat analyst consensus of $8.8B by $108.4M. Diluted EPS came in at $1.62 (+11.0% YoY), beat the $1.58 consensus by $0.04. Medtronic reports across 4 business segments, led by Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Financial Snapshot
Trailing eight quarters through Q2 2025
Q2 2025 Earnings FAQ
Common questions about Medtronic's Q2 2025 earnings report.
Medtronic (MDT) reported Q2 2025 earnings on May 21, 2025 before market open.
Medtronic reported revenue of $8.9B and diluted EPS of $1.62 for Q2 2025.
Revenue beat the consensus estimate of $8.8B by $108.4M. EPS beat the consensus estimate of $1.58 by $0.04.
Compared to the same quarter a year prior, revenue grew 3.9% from $8.6B a year earlier and diluted EPS grew 11.0% from $1.46.
You can read the 10-K periodic report (0001613103-25-000091) directly on SEC EDGAR. The filing index links above go to sec.gov.